US Patent Issued to Celgene on Nov. 18 for "Methods for treating cancer and the use of biomarkers as a predictor of clinical sensitivity to therapies" (California Inventors)

ALEXANDRIA, Va., Nov. 18 -- United States Patent no. 12,474,342, issued on Nov. 18, was assigned to Celgene Corp. (Summit, N.J.).

"Methods for treating cancer and the use of biomarkers as a predictor of clinical sensitivity to therapies" was invented by Ellen Filvaroff (San Francisco), Antonia Lopez-Girona (San Diego) and Gang Lu (San Diego).

According to the abstract* released by the U.S. Patent & Trademark Office: "A method of identifying a subject having cancer who is likely to be responsive to a treatment compound, comprising administering the treatment compound to the subject having the cancer; obtaining a sample from the subject; determining the level of a biomarker in the sample from the subject; and diagnosing the subject as being...